We have previously shown that infiltrating lymphocytes are strongly associated with improved survival in NSCLC [32, 33], but we found no correlation between markers of tumor-infiltrating lymphocytes and CXCL16 levels in cancer cells or tumor stroma. This evidence concerns the gene CXCL16 and cancer.